Related Experiment Video

Updated: Jun 19, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Proteasome inhibition: mechanism of action

George N DeMartino1

  • 1Integrative Biology Graduate Program, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9040, USA.

Journal of the National Comprehensive Cancer Network : JNCCN
|October 2, 2009
PubMed

Insights

The ubiquitin-proteasome pathway regulates cell functions and protein degradation. Inhibiting proteasomes, like with bortezomib, can decrease tumor growth and increase cancer cell death.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The ubiquitin-proteasome pathway (UPP) is crucial for intracellular protein degradation and cellular function regulation.
  • Aberrant UPP activity, particularly in cell cycle control and NF-kappaB signaling, is linked to oncogenesis and metastasis.
  • The proteasome's structure and role within the UPP are key to understanding its implications in cancer.

Purpose of the Study:

  • To discuss the structure of the proteasome within the ubiquitin-proteasome pathway.
  • To highlight the role of the UPP in neoplastic growth and metastasis.
  • To explore the therapeutic potential of proteasome inhibitors in cancer treatment.

Main Methods:

  • Literature review on the ubiquitin-proteasome pathway and proteasome structure.
  • Discussion of the molecular mechanisms underlying proteasome function in cancer.
  • Analysis of the impact of proteasome inhibition on cellular processes.

Main Results:

  • The proteasome is essential for degrading most intracellular proteins, regulating critical cellular functions.
  • Dysregulation of the UPP, including altered cell cycle control and NF-kappaB signaling, contributes to malignancy.
  • Proteasome inhibitors can selectively target proteins, leading to reduced tumor cell proliferation and enhanced apoptosis.

Conclusions:

  • The ubiquitin-proteasome pathway is a significant target in cancer therapy.
  • Proteasome inhibitors demonstrate potential for decreasing tumor growth and inducing apoptosis in neoplastic diseases.
  • Targeting specific protein substrates via proteasome inhibition offers a promising strategy for cancer treatment.

More Related Videos

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...